Related Experiment Video
Updated: Jun 2, 2026
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Effects of cyclosporin A administration on gene expression in rat brain
Minoru Kawakami1, Tetsuyuki Yoshimoto, Naomi Nakagata
1Laboratory of Phylogeny, Institute of Molecular Embryology and Genetics, Kumamoto University, Japan. mkawa@gpo.kumamoto-u.ac.jp
Primary Objective:
The immunosuppressant cyclosporin A (CsA) is reported to have a strong anti-ischemic effect. Although this neuroprotective effect is speculated to be related to the blockade of a mitochondrial permeability transition pore (mPTP), the underlying molecular mechanism remains to be elucidated. This study focused on the effect of CsA on transcriptional regulation in brain cells.
Methods:
CsA and a control substance were injected into rat brains and purified extracted mRNA. Both mRNAs were compared using a cDNA subtraction technique.
Results:
Nine significantly up-regulated genes and seven significantly down-regulated genes were detected following CsA administration. All of the up-regulated genes are neurotrophic or reported to have roles in regeneration of brain tissue. Among the down-regulated genes, three are known to be detrimental to neuronal cells and are also reported to facilitate the pathology of Alzheimer's disease (AD) and four genes are related to oxidative metabolism.
Conclusions:
Strong immunosuppression would present as a side-effect during CsA use as a neuroprotectant. The results of this study will help to discriminate between the CsA immunosuppressive effect and the neuroprotective effect at the molecular level and may lead to the development of new conceptual and pharmacological tools.
Insights
Cyclosporin A (CsA) shows neuroprotective effects by altering gene expression in brain cells. This study identifies specific genes regulated by CsA, aiding in distinguishing its immunosuppressive from neuroprotective actions.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Cyclosporin A (CsA) exhibits anti-ischemic and neuroprotective properties.
- The precise molecular mechanisms underlying CsA's neuroprotection, particularly its effect on the mitochondrial permeability transition pore (mPTP), require further investigation.
- Understanding CsA's impact on transcriptional regulation in brain cells is crucial.
Purpose of the Study:
- To investigate the effect of CsA on transcriptional regulation in rat brain cells.
- To identify specific genes that are up-regulated or down-regulated following CsA administration.
- To differentiate the molecular mechanisms of CsA's immunosuppressive and neuroprotective effects.
Main Methods:
- Rats were administered CsA or a control substance.
- Messenger RNA (mRNA) was extracted from brain tissue.
- A cDNA subtraction technique was employed to compare gene expression profiles.
Main Results:
- CsA administration resulted in the significant up-regulation of nine genes and down-regulation of seven genes.
- Up-regulated genes were associated with neurotrophic factors and brain tissue regeneration.
- Down-regulated genes included those detrimental to neurons, implicated in Alzheimer's disease (AD) pathology, and involved in oxidative metabolism.
Conclusions:
- CsA influences the expression of genes related to neuroprotection, regeneration, and detrimental pathways.
- Distinguishing CsA's immunosuppressive side effects from its neuroprotective benefits at a molecular level is now more feasible.
- These findings may facilitate the development of novel therapeutic strategies and pharmacological tools for neuroprotection.
